Huge news IMO Phase 2 study to evaluate the safety and efficacy of CYTO-201 as a treatment to slow or halt the progression of the SARS-CoV-2 infection from mild/moderate (stage 1-2A) to severe (stage 2B-3).
“Be Fearful When Others Are Greedy and Greedy When Others Are Fearful”